Russia's Sputnik V vaccine for Covid priced at Rs 948 plus 5% GST in India

Inoculation could be cheaper when it is manufactured domestically, says Hyderabad company.

Covid-19 coronavirus
The vaccine has been developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine last week.
BS Web Team New Delhi
2 min read Last Updated : May 14 2021 | 1:00 PM IST
Russia’s Sputnik V vaccine for Covid-19 will be priced in India at Rs 948 per dose with an additional 5 per cent GST and could be cheaper when it is manufactured domestically, said Dr Reddy's Laboratories on Friday.

India will import Sputnik V frozen form from Russia this quarter. Hyderabad-based Dr Reddy's is responsible for ensuring that the vaccine remains stable and sanctity of the cold chain is maintained — from the manufacturing site in Russia to its cold chain point and eventually to all parts of India.

The first consignment of the imported vaccine landed in India on May 1 and has received regulatory clearance, said Dr Reddy's in a statement. "The imported doses of the vaccine are presently priced at an MRP of Rs 948 + 5%  GST per dose, with the possibility of a lower price point when local supply begins"

The company said is working with six manufacturing partners in India to supply the vaccine.

“As part of a limited pilot, the soft launch of the vaccine has commenced and the first dose of the vaccine was administered in Hyderabad today on May 14, 2021,” the company said in a regulatory filing with the bourses.

Sputnik V, a vaccine with 91.6 per cent efficacy--the highest among Covid vaccines available in India--requires a temperature range of -18 degrees C to -22 degrees C to remain stable.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineDr Reddy's Laboratories Limited

Next Story